US 7,410,648 B2
	Polypeptides of Moraxella (Branhamella) catarrhalis
Denis Martin, St. Augustin-de-Desmaures (Canada); Josée Hamel, Sillery (Canada); Bernard R. Brodeur, Sillery (Canada); Stéphane Rioux, Beauport (Canada); and Julie Couture, St-Augustin-de-Desmaures (Canada)
Assigned to ID Biomedical Corporation, Laval (Canada)
Appl. No. 10/495,643 PCT Filed Nov. 15, 2002, PCT No. PCT/CA02/01760 § 371(c)(1), (2), (4) Date Oct. 25, 2004, PCT Pub. No. WO03/043986, PCT Pub. Date May 30, 2003.
Claims priority of provisional application 60/331441, filed on Nov. 16, 2001.
Prior Publication US 2005/0070691 A1, Mar. 31, 2005
Int. Cl. A61K 39/02 (2006.01); A61K 39/00 (2006.01); C07H 21/04 (2006.01); C07K 14/00 (2006.01); C12P 21/04 (2006.01)

U.S. Cl. 424—251.1  [424/234.1; 424/190.1; 424/184.1; 530/350; 530/300; 536/23.7; 536/23.4; 435/340; 435/331; 435/252.3; 435/69.7]

11 Claims

1. An isolated polypeptide consisting of an amino acid sequence at least 90% identical to the amino acid sequence set forth as SEQ ID NO:2, wherein the polypeptide is capable of eliciting an antibody that specifically bonds to a protein consisting of the amino acid sequence set forth as SEQ ID NO:2, and wherein the polypeptide is capable of eliciting an immune response against Moraxella catarrhalis.